Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/25248
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDrago-Ferrante, Rosa-
dc.contributor.authorPentimalli, Francesca-
dc.contributor.authorCarlisi, Daniela-
dc.contributor.authorBlasio, Anna de-
dc.contributor.authorSaliba, Christian-
dc.contributor.authorBaldacchino, Shawn-
dc.contributor.authorDeGaetano, James-
dc.contributor.authorDebono, Joseph-
dc.contributor.authorCaruana-Dingli, Gordon-
dc.contributor.authorGrech, Godfrey-
dc.contributor.authorScerri, Christian A.-
dc.contributor.authorTesoriere, Giovanni-
dc.contributor.authorGiordano, Antonio-
dc.contributor.authorVento, Renza-
dc.contributor.authorDi Fiore, Riccardo-
dc.date.accessioned2018-01-02T11:13:10Z-
dc.date.available2018-01-02T11:13:10Z-
dc.date.issued2017-
dc.identifier.citationDrago-Ferrante, R., Pentimalli, F., Carlisi, D., De Blasio, A., Saliba, C., Baldacchino, S.,...Di Fiore, R. (2017). Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation. Oncotarget, 8(17), 1-20.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar//handle/123456789/25248-
dc.description.abstractMiR-29 family dysregulation occurs in various cancers including breast cancers. We investigated miR-29b-1 functional role in human triple negative breast cancer (TNBC) the most aggressive breast cancer subtype. We found that miR-29b-1-5p was downregulated in human TNBC tissues and cell lines. To assess whether miR- 29b-1-5p correlated with TNBC regenerative potential, we evaluated cancer stem cell enrichment in our TNBC cell lines, and found that only MDA-MB-231 and BT-20 produced primary, secondary and tertiary mammospheres, which were progressively enriched in OCT4, NANOG and SOX2 stemness genes. MiR-29b-1-5p expression inversely correlated with mammosphere stemness potential, and miR-29b-1 ectopic overexpression decreased TNBC cell growth, self-renewal, migration, invasiveness and paclitaxel resistance repressing WNT/βcatenin and AKT signaling pathways and stemness regulators. We identified SPINDLIN1 (SPIN1) among predicted miR-29b- 1-5p targets. Consistently, SPIN1 was overexpressed in most TNBC tissues and cell lines and negatively correlated with miR-29b-1-5p. Target site inhibition showed that SPIN1 seems to be directly controlled by miR-29b-1-5p. Silencing SPIN1 mirrored the effects triggered by miR-29b-1 overexpression, whereas SPIN1 rescue by SPIN1miScript protector, determined the reversal of the molecular effects produced by the mimic-miR-29b-1-5p. Overall, we show that miR-29b-1 deregulation impacts on multiple oncogenic features of TNBC cells and their renewal potential, acting, at least partly, through SPIN1, and suggest that both these factors should be evaluated as new possible therapeutic targets against TNBC.en_GB
dc.description.sponsorshipThis study was partially funded by the European Regional Development Fund, European Territorial Cooperation 2007-2013, CCI 2007 CB 163 PO 037, OP Italia-Malta 2007-2013; the Italian Ministry of Education, University and Research (MIUR) ex-60%, 2013; R. Di Fiore and R. Drago-Ferrante were recipients of fellowships granted by the European Regional Development Fund, European Territorial Cooperation 2007-2013, CCI 2007 CB 163 PO 037, OP Italia-Malta 2007-2013; D. Carlisi was a recipient of a fellowship granted by MIUR (contract no. 82, January 23, 2014).en_GB
dc.language.isoenen_GB
dc.publisherImpact Journalsen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectBreast -- Canceren_GB
dc.subjectMicroRNAen_GB
dc.titleSuppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulationen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedpeer-revieweden_GB
dc.identifier.doi10.18632/oncotarget.15960-
dc.publication.titleOncotargeten_GB
Appears in Collections:Scholarly Works - FacM&SPat



Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.